User:Mr. Ibrahem/Ospemifene
From Wikipedia, the free encyclopedia
Ospemifene, sold under the brand names Osphena and Senshio, is a medication used to treat vaginal atrophy in women after menopause.[1] It is used when estrogen cannot be applied.[1] It is taken by mouth.[1]
Quick Facts Clinical data, Trade names ...
Clinical data | |
---|---|
Trade names | Osphena; Senshio |
Other names | Deaminohydroxytoremifene |
AHFS/Drugs.com | Monograph |
License data |
|
Pregnancy category |
|
Routes of administration | By mouth |
Drug class | Selective estrogen receptor modulator |
Legal status | |
Legal status |
|
Identifiers | |
| |
Chemical and physical data | |
Formula | C24H23ClO2 |
Molar mass | 378.90 g·mol−1 |
3D model (JSmol) | |
| |
|
Close
Common side effects include vaginal candidiasis, hot flushes, headache, muscle spasms, rash, and vaginal bleeding.[1] It should not be used in people with breast cancer or venous thromboembolism.[2] It is a selective estrogen receptor modulator (SERM).[1] It acts similarly to estrogen on the vagina.[1]
Ospemifene was approved for medical use in the United States in 2013 and Europe in 2015.[3][1] In the United Kingdom 4 weeks of treatment costs the NHS about £40.[2] This amount in the United States is about 210 USD.[4]